Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.
第一作者:
John M,Watkins
第一单位:
Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina, USA. watkinsm@musc.edu
作者:
医学主题词
抗肿瘤药(Antineoplastic Agents);综合疗法(Combined Modality Therapy);女(雌)性(Female);头颈部肿瘤(Head and Neck Neoplasms);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);辐射损伤(Radiation Injuries);再治疗(Retreatment);存活率(Survival Rate)
DOI
10.1002/hed.20986
PMID
19156831
发布时间
2018-12-01
- 浏览32
Head & neck
493-502页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



